Smith & Nephew 

€13.65
415
+€0.01+0.07% Hari ini

Statistik

Harga Tertinggi Hari
13.65
Harga Terendah Hari
13.65
52M Tertinggi
-
52M Terendah
-
Volum
0
Volum Purata
-
Kapasiti Pasaran
11.94B
Nisbah P/E
42.63
Pendapatan Dividen
2.55%
Dividen
0.35

Akan Datang

Dividen

2.55%Pendapatan Dividen
Pertumbuhan 10T
4.64%
Pertumbuhan 5T
1%
Pertumbuhan 3T
2.97%
Pertumbuhan 1T
-2.18%

Pendapatan

1AugDisahkan
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0
16.07
32.13
48.2
EPS yang dijangka
0.3928
EPS sebenar
0.376

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti NPW1.F. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Stryker
SYK
Kapasiti Pasaran128.76B
Stryker Corporation adalah pesaing langsung yang menawarkan pelbagai peranti ortopedik dan perubatan yang serupa.
Medtronic
MDT
Kapasiti Pasaran108.51B
Medtronic plc mengkhusus dalam teknologi perubatan, perkhidmatan, dan penyelesaian, termasuk bagi peranti pembedahan, bersaing dalam bidang yang bertindih dengan Smith & Nephew.
Zimmer Biomet
ZBH
Kapasiti Pasaran22.53B
Zimmer Biomet Holdings, Inc. bersaing dalam pengeluaran produk penjagaan kesihatan muskuloskeletal, bertindih secara langsung dengan barisan produk Smith & Nephew.
Johnson & Johnson
JNJ
Kapasiti Pasaran383.69B
Johnson & Johnson beroperasi dalam sektor peranti perubatan melalui anak syarikatnya DePuy Synthes, yang bersaing dalam ortopedik, satu bidang utama bagi Smith & Nephew.
Boston Scientific
BSX
Kapasiti Pasaran115.23B
Boston Scientific Corporation bersaing dengan Smith & Nephew dalam pasaran peranti perubatan, terutamanya dalam bidang produk pembedahan canggih dan penjagaan luka.
Intuitive Surgical
ISRG
Kapasiti Pasaran170.21B
Intuitive Surgical, Inc. menawarkan sistem pembedahan yang dibantu robot, bersaing dengan teknologi pembedahan canggih Smith & Nephew.
Abbott Laboratories
ABT
Kapasiti Pasaran193.13B
Abbott Laboratories bersaing dalam pelbagai segmen penjagaan kesihatan, termasuk peranti perubatan yang bertindih dengan portfolio Smith & Nephew.
Baxter International
BAX
Kapasiti Pasaran18.43B
Baxter International Inc. menyediakan pelbagai produk hospital dan pembedahan, bersaing dalam sektor bekalan dan peranti perubatan.
Globus Medical
GMED
Kapasiti Pasaran9.91B
Globus Medical, Inc. adalah syarikat yang memberi tumpuan kepada pembedahan tulang belakang dan ortopedik, bersaing secara langsung dengan Smith & Nephew di pasaran pembedahan ortopedik.
Edwards Lifesciences
EW
Kapasiti Pasaran41.52B
Edwards Lifesciences Corporation mengkhusus dalam produk jantung dan penjagaan kritikal, bersaing secara tidak langsung dalam pasaran peranti perubatan.

Mengenai

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Show more...
CEO
Dr. Deepak S. Nath Ph.D.
Pekerja
18000
Negara
GB
ISIN
GB0009223206
WKN
000502816

Penyenaraian